Parkside Financial Bank & Trust’s PTC Therapeutics PTCT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.2K	Buy	76 +2	+3%	+$144	﹤0.01%	1825
2026 Q1	$5.04K	Hold	74	–	–	﹤0.01%	1819
2025 Q4	$5.62K	Buy	74 +15	+25%	+$1.09K	﹤0.01%	1764
2025 Q3	$3.62K	Sell	59 -7	-11%	-$365	﹤0.01%	1828
2025 Q2	$3.22K	Buy	66 +26	+65%	+$1.23K	﹤0.01%	1847
2025 Q1	$2.04K	Buy	+40	New	+$2K	﹤0.01%	1881

Other funds holding PTCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Parkside Financial Bank & Trust's PTCT Position: Q2 2026 in Review

Parkside Financial Bank & Trust increased its PTC Therapeutics (PTCT) stake by 2.7% in Q2 2026, buying an estimated $144 and bringing the position to 76 shares worth $6.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1825.

Parkside Financial Bank & Trust first reported a position in PTCT in Q1 2025 and has held it in 6 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

Parkside Financial Bank & Trust held 76 shares of PTC Therapeutics worth $6.2K as of Q2 2026.
Parkside Financial Bank & Trust bought 2 PTC Therapeutics shares in Q2 2026, an estimated $144.
PTC Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1825 holding.
Parkside Financial Bank & Trust first reported a position in PTC Therapeutics in Q1 2025 and has held it in 6 quarters since.
382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.